153 related articles for article (PubMed ID: 25343552)
21. A functional polymorphism in microRNA-196a2 is associated with increased susceptibility to non-Hodgkin lymphoma.
Li T; Niu L; Wu L; Gao X; Li M; Liu W; Yang L; Liu D
Tumour Biol; 2015 May; 36(5):3279-84. PubMed ID: 25501512
[TBL] [Abstract][Full Text] [Related]
22. Single nucleotide polymorphisms of microRNA processing genes and outcome of non-Hodgkin's lymphoma.
Gao Y; Diao L; Li H; Guo Z
Onco Targets Ther; 2015; 8():1735-41. PubMed ID: 26203264
[TBL] [Abstract][Full Text] [Related]
23. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
Zhang Y; Chen MB; Zhou XY; Hong XN
PLoS One; 2013; 8(6):e66411. PubMed ID: 23840460
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism (rs16917496) at the miR-502 Binding Site of the Lysine Methyltransferase 5A (
Mosallayi M; Simonian M; Khosravi S; Salehi AR; Khodadoostan M; Sebghatollahi V; Baradaran A; Salehi R
Adv Biomed Res; 2017; 6():77. PubMed ID: 28808643
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.
Peckham-Gregory EC; Thapa DR; Martinson J; Duggal P; Penugonda S; Bream JH; Chang PY; Dandekar S; Chang SC; Detels R; Martínez-Maza O; Zhang ZF; Hussain SK
Cancer Epidemiol; 2016 Dec; 45():47-57. PubMed ID: 27701053
[TBL] [Abstract][Full Text] [Related]
26. MiR-502/SET8 regulatory circuit in pathobiology of breast cancer.
Liu B; Zhang X; Song F; Zheng H; Zhao Y; Li H; Zhang L; Yang M; Zhang W; Chen K
Cancer Lett; 2016 Jul; 376(2):259-67. PubMed ID: 27080302
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in microRNA binding site of
Peng C; Zhao Y; Zhang X; Zhang J; Sha Z; Zhang S
Exp Ther Med; 2023 Jun; 25(6):244. PubMed ID: 37153888
[TBL] [Abstract][Full Text] [Related]
28. A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma.
Liu Y; Cai H; Liu J; Fan H; Wang Z; Wang Q; Shao M; Sun X; Diao J; Liu Y; Shi Y; Fan Q
Biochem Biophys Res Commun; 2013 Mar; 432(4):660-5. PubMed ID: 23416081
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
[TBL] [Abstract][Full Text] [Related]
30. miR-502-mediated histone methyltransferase
Zhang S; Guo Z; Xu J; Wang J; Zhang J; Cui L; Zhang H; Liu Y; Bai Y
Oncol Lett; 2017 Dec; 14(6):7131-7138. PubMed ID: 29250163
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
34. A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.
De Ruyck K; Duprez F; Ferdinande L; Mbah C; Rios-Velazquez E; Hoebers F; Praet M; Deron P; Bonte K; Speel EJ; Libbrecht L; De Neve W; Lambin P; Thierens H
Cancer Epidemiol; 2014 Oct; 38(5):591-8. PubMed ID: 25127693
[TBL] [Abstract][Full Text] [Related]
35. A genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancer.
Song P; Zhu H; Zhang D; Chu H; Wu D; Kang M; Wang M; Gong W; Zhou J; Zhang Z; Zhao Q
Sci Rep; 2014 Nov; 4():7080. PubMed ID: 25399950
[TBL] [Abstract][Full Text] [Related]
36. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in immune function genes and non-Hodgkin lymphoma survival.
Aschebrook-Kilfoy B; Zheng T; Foss F; Ma S; Han X; Lan Q; Holford T; Chen Y; Leaderer B; Rothman N; Zhang Y
J Cancer Surviv; 2012 Mar; 6(1):102-14. PubMed ID: 22113576
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experience.
Ko OB; Lee DH; Kim SW; Lee JS; Kim S; Huh J; Suh C
Korean J Intern Med; 2009 Jun; 24(2):128-34. PubMed ID: 19543491
[TBL] [Abstract][Full Text] [Related]
39. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
[TBL] [Abstract][Full Text] [Related]
40. Functional Polymorphism Located in the microRNA Binding Site of the Insulin Receptor (INSR) Gene Confers Risk for Type 2 Diabetes Mellitus in the Bangladeshi Population.
Parvin M; Jahan F; Sarkar PK; Howlader ZH; Nabi AHMN; Hosen MI
Biochem Genet; 2019 Feb; 57(1):20-33. PubMed ID: 29971619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
